The level of intracellular tyrosinase activities after only α-MSH treatment was 313%, which decreased to 91.5% and 79.5% upon pretreatment with 0.5 and 1% (v/v) CFS, respectively. This evidence concerns the gene TYR and myalgic encephalomeyelitis/chronic fatigue syndrome.